Antimicrobial Resistance refers to the ability of microorganisms to survive or continue multiplying when exposed to antimicrobial medicines that would previously have inhibited or killed them. The term is broader than antibiotic resistance because antimicrobials include drugs directed against bacteria, viruses, fungi and parasites. Resistance can therefore involve antibacterial, antiviral, antifungal or antiparasitic medicines. It is a biological phenomenon that evolves in microbial populations through genetic variation and selection, but human behaviour strongly influences its development and spread through patterns of antimicrobial use, infection transmission, healthcare practices, agriculture and environmental contamination.
Resistance can arise through spontaneous genetic mutations or acquisition of resistance genes from other microorganisms. Bacteria are particularly capable of horizontal gene transfer, in which genetic material can move between organisms through mechanisms such as conjugation, transformation and transduction. Resistance mechanisms include enzymatic destruction or modification of a drug, alteration of the antimicrobial's target, reduced permeability, active efflux and metabolic bypass. A single microorganism can acquire multiple mechanisms, producing multidrug resistance. The biological details differ among bacterial, viral, fungal and parasitic pathogens because their genomes, replication processes and drug targets are fundamentally different.
Antimicrobial exposure creates selection pressure. When a population containing susceptible and resistant organisms encounters an antimicrobial, susceptible organisms may be inhibited or eliminated while organisms with resistance mechanisms survive and reproduce. Resistance therefore does not arise simply because an individual person becomes accustomed to a medicine. It is a characteristic of microorganisms that can be selected and propagated. Inappropriate antimicrobial use can increase selection pressure, but resistance can also emerge during appropriate treatment because microorganisms naturally evolve and antimicrobial exposure cannot completely eliminate this possibility.
Antimicrobial Resistance can spread between people, animals and environments. Resistant organisms can move through direct contact, contaminated surfaces, food, water, healthcare settings, communities and international travel. Resistance genes can circulate through microbial populations even when the original organism is not itself transmitted. The interconnected nature of human, animal and environmental health is one reason antimicrobial resistance is often approached through a One Health framework. Hospitals can be important environments for transmission because vulnerable patients, intensive antimicrobial use and invasive procedures can coexist, but resistance is not confined to healthcare facilities.
Antimicrobial stewardship aims to ensure that antimicrobial medicines are used only when appropriate and, when needed, that the correct medicine, dose, route and duration are selected. Stewardship is not synonymous with simply reducing antimicrobial prescriptions. Unnecessary treatment should be avoided, but delaying necessary treatment can also cause harm. Stewardship programmes use diagnostic information, local resistance data, prescribing guidelines, review and de-escalation practices, and education to improve antimicrobial use. The objective is to preserve effectiveness while ensuring individual patients receive appropriate treatment.
Infection prevention is a major component of controlling Antimicrobial Resistance because preventing infection reduces the need for antimicrobial treatment and reduces opportunities for resistant organisms to spread. Hand hygiene, environmental cleaning, appropriate sterilisation and disinfection, vaccination, isolation procedures and safe healthcare practices can all contribute. Laboratory surveillance allows institutions and public-health authorities to identify resistance patterns and detect outbreaks. These measures demonstrate that resistance cannot be solved through drug development alone because reducing transmission and preventing infections also reduce selection and spread.
The consequences of Antimicrobial Resistance include increased treatment complexity, longer illness, greater healthcare utilisation and higher risk of complications when effective medicines become limited. Resistance does not mean that an infection is automatically untreatable; alternative antimicrobials may remain effective, and susceptibility testing can help guide treatment for many bacterial infections. However, resistance can substantially narrow therapeutic choices and sometimes leaves organisms susceptible only to medicines that are more toxic, less effective or more difficult to administer. The public-health significance therefore depends on the pathogen, resistance mechanism, site of infection and available therapeutic alternatives.
Antimicrobial Resistance is frequently used incorrectly as a synonym for antibiotic resistance. Antibiotic resistance is one component of the broader antimicrobial-resistance problem and specifically concerns bacteria resisting antibacterial drugs. Viruses do not become antibiotic-resistant because antibiotics do not act against viruses in the first place, although viruses can develop antiviral resistance. Understanding this distinction is important for accurate communication, surveillance and treatment. The broader concept also explains why antimicrobial resistance requires coordinated approaches involving medicine, microbiology, infection control, agriculture, veterinary practice, environmental management and public health.
